(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 4.78% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.75%.
Rxsight's revenue in 2026 is $121,828,000.On average, 12 Wall Street analysts forecast RXST's revenue for 2026 to be $6,275,965,949, with the lowest RXST revenue forecast at $5,878,896,217, and the highest RXST revenue forecast at $6,559,826,782. On average, 12 Wall Street analysts forecast RXST's revenue for 2027 to be $4,949,325,365, with the lowest RXST revenue forecast at $4,356,446,166, and the highest RXST revenue forecast at $5,413,481,852.
In 2028, RXST is forecast to generate $5,709,921,452 in revenue, with the lowest revenue forecast at $4,971,967,145 and the highest revenue forecast at $7,558,580,850.